Search Results
Results found for "Yang Du"
- Conjugation Strategies for Probe Development
It also poses some disadvantages – just like acid-amine amide coupling, some byproducts are obtained during
- Is Your GPCR Drug Discovery Program Built for Breakthroughs or Breakdowns?
better systems, but in reality, our most brilliant and expensive minds are stuck with low-impact tasks due
- The Imprecision Problem: Why Your GPCR Drug Discovery Program Is Off-Track Before It Even Starts
But because the program is run on duct tape and heroics instead of precision.
- Misread the Curve, Misjudge the Drug: Rethinking Antagonism in GPCR Pharmacology
Competitive antagonism occurs when agonist and antagonist re-equilibrate rapidly during the experiment
- Decoding Olfactory GPCRs: How AlphaFold and AI Are Changing the Game
Their structures are hard to determine experimentally due to poor expression and the volatility of odorant
- How Fast Does a Drug Work?
When does onset rate dictate therapeutic onset, and when does offset rate predict duration?
- Building Backwards: Why Top-Down Models Could Revolutionize Pain Research
Learning from COVID-19 One striking example came from his COVID-19 work during his PhD.
- Understanding Orthosteric Binding: The Key to Drug Action
Often, a low EC50 indicates high potency, but this isn't always the case due to various biological factors
- Why Sokhom Pin Never Left GPCRs, Even When Everyone Else Did
Riding the GPCR Rollercoaster Early in his career at DuPont and BMS, GPCRs were red hot.
- Pharmacology Isn't What You Think—It's So Much More
Ever wondered why a drug behaves like a miracle in one tissue and a dud in another?
- The Chemistry of Confidence: Aha Moments That Shape Scientific Careers
Getting accepted into a PhD program during a personally difficult time.
- From Multiplex to Models: Scaling Up GPCR Discovery in the Post-Silo Era
Building for the Future The Sakmar lab built a system to meet that need: Dual-epitope tagged constructs
- From One to Many: How a GPCR Curiosity Became a Field-Wide Toolkit
What emerged was a dual-tagged GPCR library (DUET constructs), now publicly available via Addgene ,
- Inside Out: Mapping GPCRs from Membrane Codes to Market Moves
From dual-epitope tagging to scalable multiplex assays, this conversation dives deep into the tools now
- Reflections on My PhD Journey: Lessons Learned
You Go The PhD journey is often compared to a rollercoaster, and I found this to be especially true during
- An overview of the compartmentalized GPCR Signaling: Relevance and Implications
N., Castro, M., Wang, B., Bouley, R., Potts, J. T., Gardella, T. J., & Vilardaga, J. P. (2009).
- GPCR Weekly Whirlwind: Top Receptor Highlights from Sep 30 - Oct 6, 2024!
Postsynaptic Density Proteins and Their Role in the Trafficking of Group I Metabotropic Glutamate Receptors Dual
- Targeted Drug Design through GPCR Mutagenesis: Insights from β2AR
conservation of these residues can lead to the development of drugs that are less likely to lose effectiveness due Deep mutational scanning, for instance, is gaining popularity as a strategy due to its ability to comprehensively
- AlphaFold’s Breakthrough in GPCR Research: Revolutionizing Discovery, Yet Awaiting Experimental Proof
structural templates, allowing it to predict structures for GPCRs that were previously difficult to model due models revealed distinct ligand-binding site shapes, enabling the prioritization of different chemotypes during
- 📢 Early Bird Registration Ends Tomorrow! | Sep 16 - 22, 2024
Google DeepMind And Isomorphic Labs Are Making Rapid Progress In Biology And Drug Discovery GLP-1/FGF21 dual
- Biased Agonism at the GLP-1 Receptor: A Pathway to Improved Therapeutic Outcomes
effectively leveraged in drug discovery, as demonstrated by the development of tirzepatide, a GLP-1R/GIPR dual Willard, F.S., et al., Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist.
- APEX2/AUR Biosensor: A Powerful Tool for Protein Interaction and Trafficking
During this process, APEX2 can label proteins in the vicinity, allowing the capture of a snapshot of
- 📰 GPCR Buzz: August 5-11, 2024 | Top Highlights from DrGPCR University!
Dates: September 5 to 26, 2024 What You’ll Learn during the four sessions: How to measure pharmacologic Dates: October 3 to 31, 2024 What You’ll Master during the five sessions: Utilizing new cellular assays
- Do You Believe AI Could Accelerate Drug Discovery?
However, the impact on structure-based ligand discovery remained uncertain due to the necessity for accurately Science https://doi.org/10.1126/science.adn6354 (2024) Abramson, J., Adler, J., Dunger, J. et al.
- Canonical chemokine receptors as scavenging “decoys”
The immune system depends on chemokines to direct cell migration during immune surveillance and inflammation CCR2 is an example of a dual-function receptor that directly regulates both cell migration and scavenging
- Adhesion GPCR Consortium Newsletter - May 2024
The family of adhesion GPCRs called the Latrophilins or ADGRLs first captured my attention due to their people should absolutely experience: The Day of the Dead celebrations: This happens over the weekend during
- Extracellular signal-regulated kinases – a potential pathway for GPCR-targeted drug discovery
This emphasis may have caused other signaling pathways to be overlooked due to a need for adequate assay This dual role opens new possibilities for more complex and nuanced cellular responses.
- 📰 GPCR Weekly News, May 13 to 19, 2024
structures guide prospective ligand discovery Industry News Roche reports positive Phase Ib results for its dual
- Illuminating GPCR Research: FRET and BRET-Based Sensors Shed Light on Cellular Signaling
However, these conventional assays often provide limited information on intermediate signaling events due
- 📰 GPCR Weekly News, April 22 to 28, 2024
increases the risk of obesity GPCR Activation and Signaling Variable CGRP family peptide signaling durations






















